Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Risk factors for hospitalization, disease severity and mortality in children and adolescents with COVID-19: Results from a nationwide German registry

J Armann, M Doenhardt, M Hufnagel, N Diffloth, F Reichert, W Haas, J Schilling, S Haller, J Hübner, A Simon, DT Schneider, J Brunner, A Trotter, M Roessler, J Schmitt, R Berner
doi: https://doi.org/10.1101/2021.06.07.21258488
J Armann
1Department of Pediatrics, University Hospital and Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jakob.armann@uniklinikum-dresden.de
M Doenhardt
1Department of Pediatrics, University Hospital and Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Hufnagel
2Division of Pediatric Infectious Diseases and Rheumatology, Department of Pediatrics and Adolescent Medicine, University Medical Center, Medical Faculty, University of Freiburg, Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N Diffloth
1Department of Pediatrics, University Hospital and Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F Reichert
3Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
10Postgraduate Training for Applied Epidemiology (PAE), Robert Koch Institute, Berlin, Germany
11European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W Haas
3Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Schilling
3Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S Haller
3Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Hübner
4Division of Pediatric Infectious Diseases, Hauner Children’s Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Simon
5Pediatric Oncology and Hematology, Children’s Hospital Medical Center. University Clinics, Saarland, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DT Schneider
6Clinic of Pediatrics, Municipal Hospital Dortmund, Dortmund, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Brunner
7Department of Pediatrics, Medical University Innsbruck, Innsbruck, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Trotter
8Children’s Hospital and Center for Perinatal Medicine, Teaching Hospital of the University of Freiburg, Singen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Roessler
9Center for Evidence-based Healthcare, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Schmitt
9Center for Evidence-based Healthcare, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R Berner
1Department of Pediatrics, University Hospital and Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective To characterize the clinical features of children and adolescents hospitalized with SARS-CoV-2 infections and to explore predictors for disease severity.

Design Nationwide prospective observational cohort study.

Setting Data collected from 169 out of 351 children’s hospitals in Germany between March 18, 2020 and April 30, 2021 and comparison with the Statutory Notification System.

Participants 1,501 children and adolescents up to 19 years of age with laboratory confirmed SARS-CoV-2 infections who were admitted to children’s hospitals and subsequently reported to the COVID-19 registry of the German Pediatric Infectious Disease Society (DGPI).

Main outcome measures Admission to intensive care, in-hospital.

Results As compared to the information in the statutory notification system, up to 30% of all children and adolescents hospitalized in Germany during the study period were reported to the DGPI registry. Median age was three years (IQR, 0-12), with 36% of reported cases being infants. Although roughly half of patients in the registry were not admitted to the hospital due to their SARS-CoV-2 infection, 72% showed infection-related symptoms during hospitalization. Preexisting comorbidities were present in 28%, most commonly respiratory disorders, followed by neurological, neuromuscular, and cardiovascular diseases. Median length of hospitalization was five days (IQR 3-10). Only 20% of patients received a SARS-CoV-2-related therapy. Infants were less likely to require therapy as compared to older children. Overall, 111 children and adolescents were admitted to intensive care units (ICU). In a fully adjusted model, patient age, trisomy 21, coinfections and primary immunodeficiencies (PID) were significantly associated with intensive care treatment. In a bivariate analysis, pulmonary hypertension, cyanotic heart disease, status post (s/p) cardiac surgery, fatty liver disease, epilepsy and neuromuscular impairment were statistically significant risk factors for ICU admission.

Conclusion Overall, a small proportion of children and adolescents was hospitalized in Germany during the first year of the pandemic. The majority of patients within our registry was not admitted due to COVID-19 suggesting an overestimation of the disease burden even in hospitalized children. Nevertheless, a large proportion of children and adolescents with confirmed COVID-19 reported in Germany could be captured. This allowed for detailed assessment of overall disease severity and underlying risk factors in our cohort. The main risk factors for COVID-19 disease associated intensive care treatment were older patient age, trisomy 21, PIDs and coinfection at the time of hospitalization.

Trial registration Registry of hospitalized pediatric patients with SARS-CoV-2 infection (COVID-19), DRKS00021506

Competing Interest Statement

Reinhard Berner and Jakob P. Armann report grants from the Federal State of Saxony during the conduct of the study. Jochen Schmitt received institutional funding for investigator-initiated research from Novartis, Sanofi, Pfizer, ALK, and acted as a consultant for Novartis, Sanofi, and Lilly unrelated to this study. The other authors have no conflicts of interest to disclose.

Clinical Trial

DRKS00021506

Funding Statement

This study was supported in part by a grant by the Federal State of Saxony. The funder of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report and in the decision to submit the paper for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics Committee of the Technische Universitaet (TU) Dresden (BO-EK-110032020)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

We share data if reasonable requests are received. Requests should be directed to the corresponding author at Jakob.armann@uniklinikum-dresden.de

  • Abbreviations

    CI
    Confidence interval
    COVID-19
    Coronavirus disease 2019
    RTA
    Rapid antigen test
    PID
    Primary Immunodeficiency
    ICU
    Intensive care unit
    h/o
    History of
    s/p
    Status post
    IQR
    Interquartile Range
    MIS-C
    Multisystem Inflammatory Syndrome in Children
    PCR
    Polymerase Chain Reaction
    PIMS
    Pediatric Inflammatory Multisystem Syndrome
    SARS-CoV-2
    Severe acute respiratory syndrome Coronavirus type 2
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted June 13, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Risk factors for hospitalization, disease severity and mortality in children and adolescents with COVID-19: Results from a nationwide German registry
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Risk factors for hospitalization, disease severity and mortality in children and adolescents with COVID-19: Results from a nationwide German registry
    J Armann, M Doenhardt, M Hufnagel, N Diffloth, F Reichert, W Haas, J Schilling, S Haller, J Hübner, A Simon, DT Schneider, J Brunner, A Trotter, M Roessler, J Schmitt, R Berner
    medRxiv 2021.06.07.21258488; doi: https://doi.org/10.1101/2021.06.07.21258488
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Risk factors for hospitalization, disease severity and mortality in children and adolescents with COVID-19: Results from a nationwide German registry
    J Armann, M Doenhardt, M Hufnagel, N Diffloth, F Reichert, W Haas, J Schilling, S Haller, J Hübner, A Simon, DT Schneider, J Brunner, A Trotter, M Roessler, J Schmitt, R Berner
    medRxiv 2021.06.07.21258488; doi: https://doi.org/10.1101/2021.06.07.21258488

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (227)
    • Allergy and Immunology (500)
    • Anesthesia (110)
    • Cardiovascular Medicine (1230)
    • Dentistry and Oral Medicine (206)
    • Dermatology (147)
    • Emergency Medicine (282)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (529)
    • Epidemiology (10011)
    • Forensic Medicine (5)
    • Gastroenterology (497)
    • Genetic and Genomic Medicine (2445)
    • Geriatric Medicine (236)
    • Health Economics (479)
    • Health Informatics (1635)
    • Health Policy (751)
    • Health Systems and Quality Improvement (633)
    • Hematology (248)
    • HIV/AIDS (531)
    • Infectious Diseases (except HIV/AIDS) (11857)
    • Intensive Care and Critical Care Medicine (625)
    • Medical Education (251)
    • Medical Ethics (74)
    • Nephrology (268)
    • Neurology (2275)
    • Nursing (139)
    • Nutrition (350)
    • Obstetrics and Gynecology (452)
    • Occupational and Environmental Health (532)
    • Oncology (1244)
    • Ophthalmology (375)
    • Orthopedics (133)
    • Otolaryngology (226)
    • Pain Medicine (155)
    • Palliative Medicine (50)
    • Pathology (324)
    • Pediatrics (729)
    • Pharmacology and Therapeutics (311)
    • Primary Care Research (282)
    • Psychiatry and Clinical Psychology (2280)
    • Public and Global Health (4826)
    • Radiology and Imaging (834)
    • Rehabilitation Medicine and Physical Therapy (488)
    • Respiratory Medicine (650)
    • Rheumatology (283)
    • Sexual and Reproductive Health (237)
    • Sports Medicine (225)
    • Surgery (266)
    • Toxicology (44)
    • Transplantation (124)
    • Urology (99)